Tarsons Products Limited (TARSONS) Earnings Call Transcripts

Tarsons Products Limited's Latest Earnings Call - Q4 FY2026

In Q4 FY '26, Tarsons Products Limited reported record quarterly revenue of INR 121 crores, marking a 7.4% year-on-year increase, while full-year revenue reached INR 426 crores, up 7.7% year-on-year. The company faced challenges in its export business, which declined by 13.4% in Q4 due to geopolitical tensions affecting global supply chains. Management indicated that domestic growth remains strong, with a 11.7% increase in domestic revenue, and expressed optimism about future performance despite ongoing raw material cost pressures and geopolitical uncertainties.

Reported metrics

Guidance from management

Management expects FY '27 PAT to remain at a moderate level but anticipates improved operating leverage from new facilities. They stated, "We expect improved operating leverage from ramping up the new facilities to aid the operational performance from FY '27."

What management said

No. Most of the companies operating in the lab consumable space in India have their own channel, and that is beneficial for all companies involved, large, big, small, medium-sized companies because just like Tarsons would not like to share distribution partners with smaller medium players or even larger multinational players. Similarly, the smaller players would also try and appoint distributors who are exclusive to ...

We are following written value method and the depreciation on machine and mold is 18% and building is 10%. So that will continue. And still in our balance sheet, INR 158 crores of CWIP is there. That will get moved to main asset segment in FY '27 and additional depreciation will come from that as well. So we expect a higher depreciation in FY '27.

What analysts pressed on

Analysts expressed concerns regarding the impact of rising raw material costs on margins and the ability to pass on these costs to customers. There were also questions about the competitive landscape, particularly regarding pricing strategies and market share against larger players and imports from China.

Main topics on the call

• Record Revenue Achievement — Tarsons achieved its highest ever quarterly revenue of INR 121 crores in Q4 FY '26, a 7.4% increase year-on-year. Management stated, "This gradual improvement in performance strengthens our confidence in the long-term gr...
• Export Business Decline — The export business saw a significant decline of 13.4% in Q4 FY '26, attributed to geopolitical tensions and supply chain disruptions. Management noted, "Factors such as nonavailability of containers, elevated freight co...
• Strong Domestic Performance — Domestic revenue grew by 11.7% year-on-year in Q4 FY '26, showcasing resilience amidst external challenges. Management highlighted, "Our domestic business demonstrated strong resilience and continued to outperform, deliv...
• Raw Material Cost Pressures — Management acknowledged that rising raw material prices have impacted margins, with gross margins declining to around 58.5% in Q4. They stated, "The gross margin has been impacted over the past couple of months by a cons...

Read the full Tarsons Products Limited transcript (Q4 FY2026) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 17 Tarsons Products Limited earnings call transcripts on record, spanning February 8, 2022 to May 25, 2026. Based on this history, Tarsons Products Limited reports quarterly. The most recent call on file is dated May 25, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

TARSONS

Exchange

NSEI

Country

IN

Sector

Health Care

Industry

Life Sciences Tools and Services

Calls on record

17

First call

February 8, 2022

Most recent

May 25, 2026

Reporting cadence

quarterly